The role of neuroinflammation on the pathogenesis of Parkinson's disease
- PMID: 20423606
- DOI: 10.5483/bmbrep.2010.43.4.225
The role of neuroinflammation on the pathogenesis of Parkinson's disease
Abstract
Parkinson's Disease (PD) is a common neurodegenerative disease characterized by the progressive degeneration of nigrostriatal dopaminergic (DA) neurons. Although the causative factors of PD remain elusive, many studies on PD animal models or humans suggest that glial activation along with neuroinflammatory processes contribute to the initiation or progression of PD. Additionally, several groups have proposed that dysfunction of the blood-brain barrier (BBB) combined with infiltration of peripheral immune cells play important roles in the degeneration of DA neurons. However, these neuroinflammatory events have only been investigated separately, and the issue of whether these phenomena are neuroprotective or neurotoxic remains controversial. We here review the current knowledge regarding the functions of these neuroinflammatory processes in the brain. Finally, we describe therapeutic strategies for the regulation of neuroinflammation with the goal of improving the symptoms of PD.
Similar articles
-
Inflammatory response in Parkinson's disease (Review).Mol Med Rep. 2014 Nov;10(5):2223-33. doi: 10.3892/mmr.2014.2563. Epub 2014 Sep 12. Mol Med Rep. 2014. PMID: 25215472 Review.
-
Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention.Arch Pharm Res. 2019 May;42(5):416-425. doi: 10.1007/s12272-019-01133-0. Epub 2019 Mar 4. Arch Pharm Res. 2019. PMID: 30830660 Review.
-
Neuron-Astrocyte Interactions in Parkinson's Disease.Cells. 2020 Dec 7;9(12):2623. doi: 10.3390/cells9122623. Cells. 2020. PMID: 33297340 Free PMC article. Review.
-
Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?Front Biosci. 2008 Jan 1;13:709-17. doi: 10.2741/2713. Front Biosci. 2008. PMID: 17981581 Review.
-
Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson's Disease.J Neuroimmune Pharmacol. 2018 Mar;13(1):100-112. doi: 10.1007/s11481-017-9766-1. Epub 2017 Sep 26. J Neuroimmune Pharmacol. 2018. PMID: 28952015 Free PMC article.
Cited by
-
Neuroprotective Effects of Metformin Through AMPK Activation in a Neurotoxin-Based Model of Cerebellar Ataxia.Mol Neurobiol. 2024 Aug;61(8):5102-5116. doi: 10.1007/s12035-023-03892-w. Epub 2024 Jan 2. Mol Neurobiol. 2024. PMID: 38165584
-
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice.Brain. 2012 Sep;135(Pt 9):2750-65. doi: 10.1093/brain/aws193. Epub 2012 Aug 21. Brain. 2012. PMID: 22915735 Free PMC article.
-
Norfluoxetine Prevents Degeneration of Dopamine Neurons by Inhibiting Microglia-Derived Oxidative Stress in an MPTP Mouse Model of Parkinson's Disease.Mediators Inflamm. 2018 Dec 30;2018:4591289. doi: 10.1155/2018/4591289. eCollection 2018. Mediators Inflamm. 2018. PMID: 30692871 Free PMC article.
-
miR-135b Plays a Neuroprotective Role by Targeting GSK3β in MPP+-Intoxicated SH-SY5Y Cells.Dis Markers. 2017;2017:5806146. doi: 10.1155/2017/5806146. Epub 2017 Apr 17. Dis Markers. 2017. PMID: 28484287 Free PMC article.
-
Interleukin-4-Mediated Oxidative Stress Is Harmful to Hippocampal Neurons of Prothrombin Kringle-2-Lesioned Rat In Vivo.Antioxidants (Basel). 2020 Oct 30;9(11):1068. doi: 10.3390/antiox9111068. Antioxidants (Basel). 2020. PMID: 33143310 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
